These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32761504)

  • 21. Functional and structural analysis of trehalose-6-phosphate phosphatase from Burkholderia pseudomallei: Insights into the catalytic mechanism.
    Suthisawat S; Gourlay LJ; Bolognesi M; Boonyuen U; Vanaporn M
    Biochem Biophys Res Commun; 2020 Mar; 523(4):979-984. PubMed ID: 31973820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactivity of the human thioltransferase (glutaredoxin) C7S, C25S, C78S, C82S mutant and NMR solution structure of its glutathionyl mixed disulfide intermediate reflect catalytic specificity.
    Yang Y; Jao Sc; Nanduri S; Starke DW; Mieyal JJ; Qin J
    Biochemistry; 1998 Dec; 37(49):17145-56. PubMed ID: 9860827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure of TcpG, the DsbA protein folding catalyst from Vibrio cholerae.
    Hu SH; Peek JA; Rattigan E; Taylor RK; Martin JL
    J Mol Biol; 1997 Apr; 268(1):137-46. PubMed ID: 9149147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical and structural study of the homologues of the thiol-disulfide oxidoreductase DsbA in Neisseria meningitidis.
    Lafaye C; Iwema T; Carpentier P; Jullian-Binard C; Kroll JS; Collet JF; Serre L
    J Mol Biol; 2009 Oct; 392(4):952-66. PubMed ID: 19631659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fragment-Based Drug Design of Selective HDAC6 Inhibitors.
    Ruzic D; Djokovic N; Nikolic K
    Methods Mol Biol; 2021; 2266():155-170. PubMed ID: 33759126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
    Hoffer L; Renaud JP; Horvath D
    J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring weak ligand-protein interactions by long-lived NMR states: improved contrast in fragment-based drug screening.
    Buratto R; Mammoli D; Chiarparin E; Williams G; Bodenhausen G
    Angew Chem Int Ed Engl; 2014 Oct; 53(42):11376-80. PubMed ID: 25196717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rationalizing the Binding Kinetics for the Inhibition of the Burkholderia pseudomallei FabI1 Enoyl-ACP Reductase.
    Neckles C; Eltschkner S; Cummings JE; Hirschbeck M; Daryaee F; Bommineni GR; Zhang Z; Spagnuolo L; Yu W; Davoodi S; Slayden RA; Kisker C; Tonge PJ
    Biochemistry; 2017 Apr; 56(13):1865-1878. PubMed ID: 28225601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fragment library screening identifies hits that bind to the non-catalytic surface of Pseudomonas aeruginosa DsbA1.
    Mohanty B; Rimmer K; McMahon RM; Headey SJ; Vazirani M; Shouldice SR; Coinçon M; Tay S; Morton CJ; Simpson JS; Martin JL; Scanlon MJ
    PLoS One; 2017; 12(3):e0173436. PubMed ID: 28346540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural and biophysical characterization of the Burkholderia pseudomallei IspF inhibitor L-tryptophan hydroxamate.
    Blain JM; Grote DL; Watkins SM; Goshu GM; Muller C; Gorman JL; Ranieri G; Walter RL; Hofstetter H; Horn JR; Hagen TJ
    Bioorg Med Chem Lett; 2021 Sep; 48():128273. PubMed ID: 34298132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ligand-Orientation Based Fragment Selection in STD NMR Screening.
    Cala O; Krimm I
    J Med Chem; 2015 Nov; 58(21):8739-42. PubMed ID: 26492576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antibacterial prodrug activator Rv2466c is a mycothiol-dependent reductase in the oxidative stress response of
    Rosado LA; Wahni K; Degiacomi G; Pedre B; Young D; de la Rubia AG; Boldrin F; Martens E; Marcos-Pascual L; Sancho-Vaello E; Albesa-Jové D; Provvedi R; Martin C; Makarov V; Versées W; Verniest G; Guerin ME; Mateos LM; Manganelli R; Messens J
    J Biol Chem; 2017 Aug; 292(32):13097-13110. PubMed ID: 28620052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virtual Screening of Peptide and Peptidomimetic Fragments Targeted to Inhibit Bacterial Dithiol Oxidase DsbA.
    Duprez W; Bachu P; Stoermer MJ; Tay S; McMahon RM; Fairlie DP; Martin JL
    PLoS One; 2015; 10(7):e0133805. PubMed ID: 26225423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unraveling the B. pseudomallei Heptokinase WcbL: From Structure to Drug Discovery.
    Vivoli M; Isupov MN; Nicholas R; Hill A; Scott AE; Kosma P; Prior JL; Harmer NJ
    Chem Biol; 2015 Dec; 22(12):1622-32. PubMed ID: 26687481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
    Maurer T
    Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure of circularly permuted DsbA(Q100T99): preserved global fold and local structural adjustments.
    Manjasetty BA; Hennecke J; Glockshuber R; Heinemann U
    Acta Crystallogr D Biol Crystallogr; 2004 Feb; 60(Pt 2):304-9. PubMed ID: 14747707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ¹H, ¹³C, ¹⁵N backbone and side chain NMR resonance assignments of BPSL1050 from Burkholderia pseudomallei.
    Gaudesi D; Quilici G; Musco G
    Biomol NMR Assign; 2014 Apr; 8(1):181-4. PubMed ID: 23616103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The structure of a Burkholderia pseudomallei immunophilin-inhibitor complex reveals new approaches to antimicrobial development.
    Norville IH; O'Shea K; Sarkar-Tyson M; Zheng S; Titball RW; Varani G; Harmer NJ
    Biochem J; 2011 Aug; 437(3):413-22. PubMed ID: 21574961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystal structures of E. coli CcmG and its mutants reveal key roles of the N-terminal beta-sheet and the fingerprint region.
    Ouyang N; Gao YG; Hu HY; Xia ZX
    Proteins; 2006 Dec; 65(4):1021-31. PubMed ID: 17019698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of fragment-based screening to the design of inhibitors of Escherichia coli DsbA.
    Adams LA; Sharma P; Mohanty B; Ilyichova OV; Mulcair MD; Williams ML; Gleeson EC; Totsika M; Doak BC; Caria S; Rimmer K; Horne J; Shouldice SR; Vazirani M; Headey SJ; Plumb BR; Martin JL; Heras B; Simpson JS; Scanlon MJ
    Angew Chem Int Ed Engl; 2015 Feb; 54(7):2179-84. PubMed ID: 25556635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.